ArticleACS medicinal chemistry letters2020

New Dual CK2/HDAC1 Inhibitors with Nanomolar Inhibitory Activity against Both Enzymes.

Loganathan Rangasamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.